Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain

  title={Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain},
  author={Kirsten A. Nyrop and O S Palsson and Rona L. Levy and Michael D Von Korff and Andrew D. Feld and Marsha Turner and William E. Whitehead},
  journal={Alimentary Pharmacology \& Therapeutics},
Aim To provide estimates of actual costs to deliver health care to patients with functional bowel disorders, and to assess the cost impact of symptom severity, recency of onset, and satisfaction with treatment. 

Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders

  • V. RanganPrashant Singh A. Lembo
  • Medicine
    Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2021
Abdominal pain is a bothersome and lifestyle limiting symptom in patients with functional bowel disorders. It is associated with decreased quality of life in affected individuals, as well as

Review article: the economic impact of the irritable bowel syndrome

A large number of people worldwide have IBS, and it has substantial impact on patients' quality of life (QoL) and is associated with considerable healthcare resource use.

Home-Based Treatment for Chronic Constipation

Careful assessment by obtaining a thorough history and physical examination with limited indicated diagnostic testing is important to identify potential underlying etiologies and to treat effectively.

The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials

Few clinical trials in chronic idiopathic constipation (CIC) patients have evaluated abdominal symptom severity and whether CIC patients with abdominal symptoms respond similarly to patients with

Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population

The aim was to determine the annual all‐cause spending and healthcare utilization in pediatric IBS, and to investigate the relationship between utilization and cost.

Functional gastrointestinal disorders in children and adolescents: Knowledge, practice and attitudes of Australian paediatricians

To investigate paediatricians' understanding of, and approaches to, the diagnosis and treatment of functional abdominal pain (FAP) and irritable bowel syndrome (IBS) in children.

Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

Gut‐focused hypnotherapy improves the symptoms of irritable bowel syndrome (IBS) with benefits being sustained for many years and relatively small numbers in published studies.

A gap in our understanding: chronic constipation and its comorbid conditions.

  • N. TalleyK. LaschC. Baum
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2009

Original article Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome

The aim of this study was to assess the effect of IBS-C on health-related quality of life (HRQOL), work productivity and activity impairment, and health care resource use.

Chronic constipation: overview and challenges

The purpose of this supplement is to address critically the reasons for the current lack of understanding of the pathophysiology of constipation and to propose avenues of future research to address these deficiencies.



The usual medical care for irritable bowel syndrome

Aims : To determine what constitutes usual medical care for irritable bowel syndrome, which patient characteristics influence choice of treatment and how satisfied patients are with care.

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

Background: The clinical assessment and investigation of irritable bowel syndrome would be greatly facilitated by the introduction of a simple, easy to use severity scoring system. Such a system,

Costs of care for irritable bowel syndrome patients in a health maintenance organization

Patients with IBS show sustained increases in health care costs relative to population controls for both lower GI services and care unrelated to lower GI problems, however, the majority of the excess resulted from medical care not directly related to lowerGI problems.

The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment : A Multinational Consensus

This book presents a single source of standardized definitions, diagnostic criteria and treatment recommendations forFunctional gastrointestinal disorders, which should no longer need to make a diagnosis of exclusion.

Design of treatment trials for functional gastrointestinal disorders

Until recently many clinical trials of functional gastrointestinal disorders (FGIDs) suffered from important weaknesses in trial design, study execution, and data analysis. This makes it difficult to

The burden of selected digestive diseases in the United States.

The most prevalent diseases were non-food-borne gastroenteritis, food-borne illness, gastroesophageal reflux disease, and irritable bowel syndrome, followed by gallbladder disease, which had the highest annual direct costs in the United States.

Rome II: the Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: a Multinational Consensus

The Rome process has had a major impact, and Rome criteria are now used for the entry into most clinical trials, so that classifications must of necessity be symptom based.

The epidemiology of irritable bowel syndrome in North America: a systematic review

Approximately 30 million people in North America meet the diagnostic criteria for IBS, however, data about the natural history of IBS is quite sparse and renewed efforts should be focused at developing appropriately designed trials of the epidemiology of Ibs.